Mitotech Company
Mitotech is focused on rapid development of break-through pharmaceutical products based on mitochondria targeted antioxidants. The unique experimentally proved properties of these molecules make them promising drug candidates for treatment of many age-related disorders. Mitotech is developing its technology with a goal to help millions of patients suffering from ophthalmic, neurodegenerative, cardiovascular, metabolic and rare genetic disorders.
Founded Date:
2009
Last Funding Type:
Venture - Series Unknown
Headquarters:
Luxembourg
Technology:
Biologics
Employee Number:
1-10
Industry:
Energetic Process
Estimated Revenue:
$1M to $10M
Total Funding:
$990K